Latest Insider Transactions at Patterson Companies, Inc. (PDCO)
This section provides a real-time view of insider transactions for Patterson Companies, Inc. (PDCO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PATTERSON COMPANIES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PATTERSON COMPANIES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
436
+3.61%
|
$10,028
$23.5 P/Share
|
|
Dec 19
2023
|
Kevin Michael Barry Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
560
-2.52%
|
$15,120
$27.18 P/Share
|
|
Dec 15
2023
|
Kevin Michael Barry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
869
-3.76%
|
$23,463
$27.0 P/Share
|
|
Dec 15
2023
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
996
-0.81%
|
$26,892
$27.0 P/Share
|
|
Dec 06
2023
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
1,868
-1.3%
|
$48,568
$26.58 P/Share
|
|
Dec 05
2023
|
Donald Zurbay President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,748
-3.84%
|
$149,448
$26.59 P/Share
|
|
Dec 01
2023
|
Kevin Michael Barry Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,627
-6.58%
|
$40,675
$25.36 P/Share
|
|
Nov 14
2023
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
538
-0.43%
|
$17,216
$32.02 P/Share
|
|
Oct 05
2023
|
Timothy E Rogan President - Dental |
SELL
Open market or private sale
|
Direct |
9,260
-18.65%
|
$268,540
$29.75 P/Share
|
|
Sep 30
2023
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
422
+3.63%
|
$9,706
$23.69 P/Share
|
|
Sep 11
2023
|
Robert Frenzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+14.04%
|
$144,072
$29.19 P/Share
|
|
Sep 11
2023
|
Philip Mc Koy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+32.55%
|
$144,072
$29.19 P/Share
|
|
Sep 11
2023
|
Ellen A Rudnick Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+6.16%
|
$144,072
$29.19 P/Share
|
|
Sep 11
2023
|
Neil A Schrimsher Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+10.82%
|
$144,072
$29.19 P/Share
|
|
Sep 11
2023
|
Meenu Agarwal Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+50.0%
|
$144,072
$29.19 P/Share
|
|
Sep 11
2023
|
Alex N Blanco Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+12.92%
|
$144,072
$29.19 P/Share
|
|
Sep 11
2023
|
John D Buck Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+5.52%
|
$144,072
$29.19 P/Share
|
|
Sep 11
2023
|
Jody H Feragen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,968
+9.15%
|
$144,072
$29.19 P/Share
|
|
Jul 19
2023
|
Timothy E Rogan President - Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-1.84%
|
$24,320
$32.46 P/Share
|
|
Jul 18
2023
|
Les B Korsh CLO & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
3,686
-4.51%
|
$117,952
$32.47 P/Share
|
|
Jul 18
2023
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
5,620
-3.62%
|
$179,840
$32.48 P/Share
|
|
Jul 14
2023
|
Kevin Michael Barry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,160
-4.32%
|
$69,120
$32.07 P/Share
|
|
Jul 14
2023
|
Kevin Michael Barry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,501
+17.25%
|
$176,032
$32.07 P/Share
|
|
Jul 14
2023
|
Samantha L Bergeson CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-1.23%
|
$4,288
$32.07 P/Share
|
|
Jul 14
2023
|
Les B Korsh CLO & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,858
-2.94%
|
$155,456
$32.07 P/Share
|
|
Jul 14
2023
|
Les B Korsh CLO & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,374
+12.64%
|
$395,968
$32.07 P/Share
|
|
Jul 14
2023
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,616
-1.45%
|
$115,712
$32.07 P/Share
|
|
Jul 14
2023
|
Kevin M Pohlman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,374
+8.88%
|
$395,968
$32.07 P/Share
|
|
Jul 14
2023
|
Timothy E Rogan President - Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-1.5%
|
$24,320
$32.07 P/Share
|
|
Jul 14
2023
|
Donald Zurbay President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,527
-5.44%
|
$560,864
$32.07 P/Share
|
|
Jul 14
2023
|
Donald Zurbay President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
28,867
+14.65%
|
$923,744
$32.07 P/Share
|
|
Jul 05
2023
|
Donald Zurbay President & CEO |
SELL
Open market or private sale
|
Direct |
1,666
-1.15%
|
$53,312
$32.34 P/Share
|
|
Jul 05
2023
|
Les B Korsh CLO & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
908
-1.21%
|
$29,056
$32.34 P/Share
|
|
Jul 01
2023
|
Donald Zurbay President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,066
+17.13%
|
$992,178
$33.26 P/Share
|
|
Jul 01
2023
|
Donald Zurbay President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,282
-1.94%
|
$75,306
$33.26 P/Share
|
|
Jul 01
2023
|
Timothy E Rogan President - Dental |
BUY
Grant, award, or other acquisition
|
Direct |
5,637
+10.02%
|
$186,021
$33.26 P/Share
|
|
Jul 01
2023
|
Timothy E Rogan President - Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
586
-1.29%
|
$19,338
$33.26 P/Share
|
|
Jul 01
2023
|
Kevin Michael Barry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,013
+21.94%
|
$198,429
$33.26 P/Share
|
|
Jul 01
2023
|
Kevin Michael Barry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-2.5%
|
$13,035
$33.26 P/Share
|
|
Jul 01
2023
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,593
+19.21%
|
$85,569
$33.26 P/Share
|
|
Jul 01
2023
|
Samantha L Bergeson CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-5.32%
|
$15,411
$33.26 P/Share
|
|
Jul 01
2023
|
Les B Korsh CLO & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,268
+9.91%
|
$272,844
$33.26 P/Share
|
|
Jul 01
2023
|
Les B Korsh CLO & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,044
-1.54%
|
$34,452
$33.26 P/Share
|
|
Jul 01
2023
|
Kevin M Pohlman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,020
+7.25%
|
$297,660
$33.26 P/Share
|
|
Jul 01
2023
|
Kevin M Pohlman Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-0.65%
|
$23,133
$33.26 P/Share
|
|
Jun 30
2023
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
247
+2.74%
|
$5,681
$23.69 P/Share
|
|
Jun 21
2023
|
Les B Korsh CLO & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
3,500
-4.9%
|
$108,500
$31.75 P/Share
|
|
Dec 15
2022
|
Kevin M Pohlman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,073
+6.99%
|
$217,971
$27.87 P/Share
|
|
Dec 15
2022
|
Kevin Michael Barry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,329
+37.17%
|
$251,883
$27.87 P/Share
|
|
Dec 05
2022
|
Kevin Michael Barry Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,443
-59.45%
|
$273,847
$29.1 P/Share
|